/IQV
IQVIA Holdings Inc.
IQV • NYSEIQV • NYSE • Healthcare
$168.43+2.15%+3.54
$168.43+2.15%(+3.54)Healthcare
GoAI Score
Sign in to unlock
Valuation
50Fair Value
Sentiment
100Bullish
Risk
64Low Risk
Momentum
17Negative
Institutional-Grade Intelligence
🏆PRO
Actionable Intelligence
AI-driven stance, execution logic & risk thresholds
Catalyst Roadmap
Event timeline with expected impact & market context
Deep Insights
Fact-checked analysis & score logic breakdown
Financial Statements
Margin Trends
Gross
26.3%▼8.6pp
Revenue after COGS
Operating
14.0%▼0.3pp
After operating expenses
Net
8.3%▼0.6pp
Bottom-line profitability
Gross Margin
Operating Margin
Net Margin
Valuation Snapshot
P/E Ratio
28.5
Price vs earnings
EV/EBITDA
15.3
Enterprise value
FCF Yield
5.3%
Cash generation
Earnings Yield
3.5%
Inverse of P/E
Capital Efficiency
11
GoAI Quality ScoreFair
ROEReturn on Equity
20.9%Strong
ROAReturn on Assets
4.5%Fair
ROICReturn on Invested Capital
8.2%Fair
Financial Health
Current RatioWeak
0.75
Short-term solvency (>1.5)
Net Debt / EBITDAHigh
4.10x
Debt repayment capacity (<3x)
Income QualityStrong
1.95
Cash backs earnings (>1)
Revenue & Profitability
Revenue
Net Income
Net Loss
Income Statement
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $16.31B | $15.40B | $14.98B | $14.41B | $13.87B |
| Gross Profit | $4.29B | $5.38B | $5.24B | $5.03B | $4.64B |
| Gross Margin | 26.3% | 34.9% | 35.0% | 34.9% | 33.5% |
| Operating Income | $2.29B | $2.20B | $1.98B | $1.80B | $1.39B |
| Net Income | $1.36B | $1.37B | $1.36B | $1.09B | $966.00M |
| Net Margin | 8.3% | 8.9% | 9.1% | 7.6% | 7.0% |
| EPS | $7.91 | $7.57 | $7.39 | $5.82 | $5.05 |
Average Price Target
$233.80▲ 38.8% Upside
Past 12 Months
12 Month Forecast
Based on 50 Wall Street analysts offering 12 month price targets for IQVIA Holdings Inc., the average price target is $233.80, with a high forecast of $258.00 and a low forecast of $210.00. The average price target represents a 38.8% increase from the current price of $168.43.
Highest
$258.00
Average
$233.80
Lowest
$210.00
Rating Distribution
Strong Buy
1
2%
Buy
36
82%
Hold
6
14%
Sell
1
2%
Strong Sell
0
0%
Recent Analyst Ratings
FirmActionRatingDate
TD Cowen▲ Upgrade
Hold→Buy
2026-03-09Barclays▲ Upgrade
Equal Weight→Overweight
2026-03-06Truist Securities● Maintain
Buy
2026-02-19Citigroup● Maintain
Neutral
2026-02-06UBS● Maintain
Buy
2026-02-06Stifel● Maintain
Buy
2026-02-06JP Morgan● Maintain
Overweight
2026-02-06Jefferies● Maintain
Buy
2026-02-06Barclays● Maintain
Equal Weight
2026-02-06TD Cowen● Maintain
Hold
2026-01-22Earnings History & Surprises
BEAT RATE
100%
Last 18 quarters
AVG SURPRISE
+1.8%
EPS vs Estimate
BEATS / MISSES
18/0
Last 18 quarters
LATEST EPS
$3.42
Q1 '26
QUARTERLY EPS TREND
Estimated
Beat
Miss
QUARTERLY DETAIL
Q1 '26
+0.6%
$3.42 vs $3.40
Q4 '25
+0.7%
$3.00 vs $2.98
Q3 '25
+1.4%
$2.81 vs $2.77
Q2 '25
+2.7%
$2.70 vs $2.63
Q1 '25
+0.3%
$3.12 vs $3.11
Q4 '24
+0.7%
$2.84 vs $2.82
Q3 '24
+3.1%
$2.64 vs $2.56
Q2 '24
+2.0%
$2.54 vs $2.49
Q1 '24
+0.7%
$2.84 vs $2.82
Q4 '23
+1.2%
$2.49 vs $2.46
Q3 '23
+2.5%
$2.43 vs $2.37
Q2 '23
+1.7%
$2.45 vs $2.41
No investor questions available.
Latest News
No news available